EUVIMEDEUVIMED entdecken
Systematische Übersicht

Long-term outcomes of bioprosthetic valves in the mitral position a systematic review of studies published over the last 20 years

Marinos Koulouroudias iD, Michele Di Mauro iD, Roberto Lorusso iD

European Journal of Cardio-Thoracic Surgery · 2023

DOI: 10.1093/ejcts/ezad384 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2023. Verfasst von Marinos Koulouroudias und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute, CARIM, University of Maastricht, Netherlands. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Bioprosthesis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES Although the use of bioprostheses for mitral valve replacement (bMVR) is on the rise, their long-term durability is not well described. Defining bMVR durability will be instrumental in setting the standard against which the performance of transcatheter mitral replacement is to be judged against. The authors of this systematic review aimed to identify, assess the quality and review the outcomes in studies reporting on long-term outcomes after bMVR published over the last 20 years. METHODS Medline, Embase and Cochrane CENTRAL were searched for studies that have reported outcomes beyond a minimum of 5 years of follow-up after bMVR. Cohort characteristics, definitions of structural valve deterioration (SVD) and outcomes were summarized. The risk of bias in included studies was assessed using the Cochrane QUIPS tool. RESULTS Twenty-one studies, including 15 833 patients, were identified. Sixty-four percent of all implants were porcine and the remaining bovine pericardial. Freedom from SVD at 10 years ranged from 58.9% to 100% and at 15 years from 58.3% to 93%. Freedom from reoperation ranged from 65% to 98.7% at 10 years and 78.5% to 91% at 15 years. Information on native valve pathology or dominant haemodynamic lesion was missing in 25% and 66% of studies, respectively. Reports of postoperative echocardiography were lacking, despite the heavy reliance on echocardiography for SVD diagnosis. CONCLUSIONS There is considerable variability in reporting bMVR long-term outcomes. As such, it is difficult to generate an unbiased, generalizable understanding of long- term outcomes after bMVR across the spectrum of mitral disease phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisHeart Valve Prosthesis ImplantationBioprosthesisHumansAnimalsCattleSwineMitral ValveReoperationProsthesis FailureAortic ValveFollow-Up StudiesTreatment Outcome

Stichwörter der Autor:innen

Bioprosthetic valveLong-term outcomesMitral valve

Autor:innen und Institutionen

  • Cardiovascular Research Institute, CARIM, University of Maastricht, Netherlands.
  • Trent Cardiac Centre, Nottingham University Hospitals, Nottingham, UK.
  • Heart & Vascular Centre, Maastricht University Medical Centre, Netherlands.

ORCID-Profile: Marinos Koulouroudias, Michele Di Mauro, Roberto Lorusso

Zitieren

APA

Koulouroudias, M., Di Mauro, M., & Lorusso, R. (2023). Long-term outcomes of bioprosthetic valves in the mitral position a systematic review of studies published over the last 20 years. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezad384

Vancouver

Koulouroudias M, Di Mauro M, Lorusso R. Long-term outcomes of bioprosthetic valves in the mitral position a systematic review of studies published over the last 20 years. European Journal of Cardio-Thoracic Surgery. 2023. doi:10.1093/ejcts/ezad384

BibTeX
@article{Koulouroudias2023,
  author = {Koulouroudias, Marinos and Di Mauro, Michele and Lorusso, Roberto},
  title = {Long-term outcomes of bioprosthetic valves in the mitral position a systematic review of studies published over the last 20 years},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2023},
  doi = {10.1093/ejcts/ezad384}
}
Kostenlos starten →